Again, I don’t think it’s special. I think it lacks objectivity. I wish the field had more objectivity. If we go down this path then we need proper licensing,

Again, I don’t think it’s special. I think it lacks objectivity. I wish the field had more objectivity. If we go down this path then we need proper licensing, certifications, and changes should be as well tested as the fda process. Aka releasing software is as rigorous as releasing a new drug.